Hand and foot wart. Plantar wart
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Treatment-resistant warts Consent to participate in the study
Exclusion criteria
Exclusion criteria: Pregnant and lactating women Children under four years old People over 65 years old Patients under immunosuppressive treatment Patients with immunodeficiency and hypersensitivity reactions Patients with vascular diseases Patients with Raynaud's phenomenon Patients with capillary filling more than two seconds Patients with rheumatological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of treatment according to the physician. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Physician global assessment.;Effectiveness of treatment according to the patient. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Patient global assessment.;Local pain. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences